Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

骨髓移植之后恶婴儿骨硬化病成骨细胞和破骨细胞。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于破骨细胞则制其溶酶体酶，制骨吸收，并降低其在骨切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

髓移植之后恶性婴儿硬化病成和破活性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于破则抑制其溶酶体酶活性，抑制吸收，并降低其在切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

髓移植之后恶性硬化病成细和破细性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于破细则抑制其溶酶体酶性，抑制吸收，并降低其在切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

髓移植之后恶性婴儿硬化病成细胞和细胞活性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于细胞则抑制其溶酶体酶活性，抑制，降低其在切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

骨髓移植之后恶性婴儿骨成骨胞和破骨胞活性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于破骨胞则抑制其溶酶体酶活性，抑制骨吸收，并降低其在骨切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

骨髓移植之后恶性婴儿骨硬化骨和破骨活性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于破骨则抑制其溶酶体酶活性，抑制骨吸收，并降低其在骨切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

骨髓移植之后恶性婴儿骨硬化病成骨破骨活性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于破骨则抑制其溶酶体酶活性，抑制骨吸收，并降低其在骨切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

髓移植之后恶性婴儿硬化病成和破活性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于破则其溶酶体酶活性，吸收，并降低其在切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

髓移植之后恶性婴儿硬化病成细和破细活性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于破细则抑制其溶酶体酶活性，抑制吸收，并降低其在切片上产生凹陷能力。

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

骨髓移植之后恶性婴儿骨硬化病成骨细胞和破骨细胞活性。

As the estrogen is combined with osteoclast, it can inhibit the activity of lysomal enzyme, inhibit bone resorption and decrease the ability of osteclast on forming cavate in bone slice.

作用于破骨细胞则抑制其溶酶体酶活性，抑制骨吸收，并降低其在骨切片产生凹陷能力。